The length of price&reimbursement negotiation procedures in Italy in the period 2021-2023 was independent from the price of medicines
Background: The duration of price&reimbursement (P&R) procedures is taken as a key performance indicator of Regulatory Agencies in Europe. In this study we have tested the hypothesis that the price of medicines may have negatively affected the duration of P&R negotiations in Italy in the...
Saved in:
Main Authors: | Raffaella Cocciolo, Paola Turella, Daniela Pilunni, Pierluigi Navarra |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2025-01-01
|
Series: | Global & Regional Health Technology Assessment |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/grhta/article/view/3259 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
by: Zheng Zhu, et al.
Published: (2025-02-01) -
Impact of the National Drug Price Negotiation policy on the price, usage, and affordability of anticancer medicines in Shandong Province, China
by: Yaqun Sun, et al.
Published: (2025-01-01) -
Common spine codes are reimbursed 13% less by Medicaid compared to Medicare, ranging from 46% to 160% by state
by: Adam P. Henderson, BS, et al.
Published: (2025-03-01) -
Experience of Student Entrepreneurs in the Implementation of Businesses Financed with Non-Reimbursable Funds
by: Dragomir Camelia-Cristina, et al.
Published: (2024-12-01) -
Reimbursement or compensation for damages caused by war: the civil law aspect
by: M. О. Parii
Published: (2024-06-01)